FISHMAN COREY N. (President & CEO) purchased 22.5% of their position (10K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $15.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/20/2023ACC: 0001209191-23-056092
DirectorOfficer· President & CEO
Since Aug 2018
+10K
Net shares
Net buyer
$15.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+10K
Price / share
$1.59
Trade value
$15.86K
% of position
22.5%
11/20/2023
44.45K→54.45K
Total
Net shares
+10K
Net value
$15.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/20/2023 | P · Purchase | +10K | $1.59 | $15.86K | 22.5% | 44.45K | 54.45K |
| Total | +10K | $15.86K | ||||||
Derivative Transactions0
No derivative transactions reported